Both in Pharmaceuticals
Rigel Pharmaceuticals Inc. (New) vs Corvus Pharmaceuticals
Over the past year RIGL returned +64.9% and CRVS returned +26.3%; their daily moves had a correlation of 0.13.
RIGL +64.9% CRVS +26.3%Growth of $1, one year, split-adjusted
| Metric | RIGL | CRVS |
|---|---|---|
| Price | $50.53 | $9.70 |
| Market cap | $943.9M | $816.0M |
| Today | −1.52% | −3.29% |
| 1 month | +7.2% | −11.0% |
| 6 months | +71.1% | −39.5% |
| Year to date | +18.0% | +26.0% |
| 1 year | +59.8% | +25.0% |
| Revenue growth (YoY) | −22.6% | — |
| Gross margin | 89.2% | — |
| Net margin | 22.0% | — |
| P/E (TTM) | 2.9× | — |
| Price / sales | 3.4× | — |
| Net cash | $56.1M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 36.5% | 51.9% |
| Short % of float | 16.3% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).